Activity of adenosine deaminase in mothers who have conceived a fetus with central nervous system malformations

Journal of Perinatal Medicine

Volumn 35, Issue 5, 2007, Pages 399-402

  Engin Üstün, Yaprak ^a,b   Üstün, Yusuf ^a   Sezgin, Bülent ^a   Karabulut, Aysun Bay ^a   Kiran, Tuba Raika ^a   Kafkasli, Ayşe ^a  

^a INONU UNIVERSITY   (Turkey)

^b INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Adenosine deaminase; CNS malformations

Indexed keywords

ADENOSINE DEAMINASE;

ADOLESCENT; ADULT; ANENCEPHALUS; BLOOD ANALYSIS; BLOOD SAMPLING; BODY MASS; CENTRAL NERVOUS SYSTEM MALFORMATION; CONCEPTION; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GESTATIONAL AGE; HUMAN; HYDROCEPHALUS; MAJOR CLINICAL STUDY; MATERNAL BLOOD; PREGNANT WOMAN; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SAMPLE SIZE; SPINA BIFIDA;

ADENOSINE DEAMINASE; ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; FETAL DISEASES; HUMANS; NERVOUS SYSTEM MALFORMATIONS; PREGNANCY; ROC CURVE;

EID: 34547756524     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2007.069     Document Type: Conference Paper

References (16)

1. Detrait ER, George TM, Etchevers HC, Gilbert JR, Vekemans M, Speer MC. Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol Teratol. 2005;27:515-24.
2. Fantel AG, Mackler B, Stamps LD, Tran TT, Person RE. Reactive oxygen species and DNA oxidation in fetal rat tissues. Free Radical Biol Med. 1998;25:95-103.
3. Fischer D, Martin B, Wayden V, Synderman R. A role of adenosine deaminase in human monocyte maturation. J Clin Invest. 1976;58:399-407.
4. Giuisti G. Adenosine deaminase. In: Bergmeyer HU, editor. Methods of enzymatic analysis. New York: Academic Press; 1974:1092-8.
5. Himmetoglu O, Tiras MB, Gursoy R, Karabacak O, Sahin I, Onan A. The incidence of congenital malformations in a Turkish population. Int J Gynecol Obstet. 1996;55:117-121.
6. Koehler LH, Benz EJ. Serum adenosine deaminase: methodology and clinical applications. Clin Chem. 1962;8:133-40.
7. Martin J, Gibert MJ, Pintos C, Noguera A, Besalduch A, Obrador A. Oxidative stress in mothers who have conceived fetus with neural tube defects: the role of aminothiols and selenium. Clinic Nutr. 2004;23:507-14.
8. Mitchell LE, Adzick NS, Melchionne J, Pasquariello PS, Sutton LN, DPhil ASW. Spina bifida. Lancet. 2004;364:1885-95.
9. Moncada SE, Palmer RM, Higgs A. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-41.
10. Paidas M, Cohen A. Disorders of the central nervous system. Sem Perinatol. 1994;18:266-82.
11. Pooh RK, Maeda K, Pooh KH, Kurjak A. Sonographic assessment of the fetal brain morphology. Prenat Neonat Med. 1999;4:18-38.
12. Schubert P, Kreutzberg GW. Cerebral protection by adenosine. Acta Neurochirurg. 1993;57:80-8.
13. Sutton LN, Sun P, Adzick NS. Fetal neurosurgery. Neurosurgery. 2001;48:124-44.
14. Verity MA. Oxidative damage and repair in the developing nervous system. Neurotoxicol. 1994;15:81-91.
15. Xia Y, Khatchikian G, Zweier JL. Adenosine deaminase inhibition prevents free radical mediated injury in the postischemic heart. J Biol Chem. 1996;271:10096-102.
16. Zidek Z. Adenosine-cyclic AMP pathways and cytokine expression. Eur Cytokine Netw. 1999;10:319-28.